Compare MRNA & HPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | HPE |
|---|---|---|
| Founded | 2010 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 70.5B |
| IPO Year | 2018 | 2015 |
| Metric | MRNA | HPE |
|---|---|---|
| Price | $198.47 | $61.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 19 |
| Target Price | ★ $34.27 | $26.82 |
| AVG Volume (30 Days) | 13.5M | ★ 19.6M |
| Earning Date | 05-01-2026 | 06-02-2026 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ 1.82 |
| Revenue | $19,263,000,000.00 | ★ $34,296,000,000.00 |
| Revenue This Year | $9.36 | $20.37 |
| Revenue Next Year | $15.43 | $5.67 |
| P/E Ratio | ★ N/A | $34.51 |
| Revenue Growth | 4.29 | ★ 13.84 |
| 52 Week Low | $22.28 | $19.84 |
| 52 Week High | $202.67 | $65.65 |
| Indicator | MRNA | HPE |
|---|---|---|
| Relative Strength Index (RSI) | 75.87 | 58.19 |
| Support Level | $43.35 | $43.63 |
| Resistance Level | N/A | $63.28 |
| Average True Range (ATR) | 11.47 | 3.18 |
| MACD | 2.59 | 0.25 |
| Stochastic Oscillator | 86.71 | 59.55 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure.